| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA)
SNOA Technical Analysis
4
| As on 8th May 2025 SNOA STOCK Price closed @ 3.21 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.63 & Strong Buy for SHORT-TERM with Stoploss of 0.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNOASTOCK Price
| Open | 3.05 | Change | Price | % |
| High | 3.25 | 1 Day | 0.16 | 5.25 |
| Low | 3.05 | 1 Week | -0.74 | -18.73 |
| Close | 3.21 | 1 Month | 0.07 | 2.23 |
| Volume | 77770 | 1 Year | 3.05 | 1906.25 |
| 52 Week High 5.20 | 52 Week Low 0.13 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| DGLY | 0.06 | 20.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 117.37 | 0.26% |
| LMDX | 0.02 | 0.00% |
| PLUG | 0.85 | 8.97% |
| AKTS | 0.04 | 0.00% |
| TSLA | 284.82 | 3.11% |
| ZKIN | 2.52 | 123.01% |
| VEEE | 7.45 | 192.16% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SNOA Daily Charts |
SNOA Intraday Charts |
Whats New @ Bazaartrend |
SNOA Free Analysis |
|
|
SNOA Important Levels Intraday
| RESISTANCE | 3.60 |
| RESISTANCE | 3.47 |
| RESISTANCE | 3.40 |
| RESISTANCE | 3.32 |
| SUPPORT | 3.10 |
| SUPPORT | 3.02 |
| SUPPORT | 2.95 |
| SUPPORT | 2.82 |
SNOA Forecast May 2025
| 4th UP Forecast | 3.46 |
| 3rd UP Forecast | 3.38 |
| 2nd UP Forecast | 3.33 |
| 1st UP Forecast | 3.28 |
| 1st DOWN Forecast | 3.14 |
| 2nd DOWN Forecast | 3.09 |
| 3rd DOWN Forecast | 3.04 |
| 4th DOWN Forecast | 2.96 |
SNOA Weekly Forecast
| 4th UP Forecast | 3.34 |
| 3rd UP Forecast | 3.30 |
| 2nd UP Forecast | 3.27 |
| 1st UP Forecast | 3.25 |
| 1st DOWN Forecast | 3.17 |
| 2nd DOWN Forecast | 3.15 |
| 3rd DOWN Forecast | 3.12 |
| 4th DOWN Forecast | 3.08 |
SNOA Forecast2025
| 4th UP Forecast | 14.39 |
| 3rd UP Forecast | 10.8 |
| 2nd UP Forecast | 8.59 |
| 1st UP Forecast | 6.37 |
| 1st DOWN Forecast | 0.05 |
| 2nd DOWN Forecast | -2.17 |
| 3rd DOWN Forecast | -4.38 |
| 4th DOWN Forecast | -7.97 |
Sonoma Pharmaceuticals Inc ( NASDAQ USA Symbol : SNOA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNOA Business Profile
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; Lasercyn gel intended for the management of minor skin irritations; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Gramaderm for the treatment of topical mild to moderate acne; Microsafe, a surface disinfectant; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia. Address: 645 Molly Lane, Woodstock, GA, United States, 30189
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service